AstraZeneca's GLP-1 Pill Shows Potential in Treating Obesity and Diabetes
Recent mid-stage trials indicate that AstraZeneca's GLP-1 pill may offer benefits for obesity and diabetes, although its effectiveness compared to other treatments is still unclear.
Editorial Staff 3 days ago